Lori Nield

Lori Nield Ph.D.

Associate Research Professor
Pharmaceutical Sciences
  • Skaggs School of Pharmacy and Pharmaceutical Sciences

Email Address: lori.nield@cuanschutz.edu

Primary Phone: 720-857-5604

Recent Publications


Office Location:

Pharmacy and Pharmaceutical Sciences Building (V20)
Floor Room

Research Interests:

  • Murine models of adenocarcinoma and squamous cell carcinoma
  • Chemoprevention of lung cancer using PGI2 and PPARgamma agonists
  • Prevention of lung cancer by targeting tumor associated macrophages
  • Use of precision cut lung slices to screen chemopreventive agents

Representative publications:

Fritz JM, Tennis MA, Orlicky DJ, Lin H, Ju C, Redente EF, Choo KS, Staab TA, Bouchard RJ, Merrick DT, Malkinson AM, Dwyer-Nield LD. Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas. Frontiers in immunology. 2014; 5:587.

Ghosh M, Dwyer-Nield LD, Kwon JB, Barthel L, Janssen WJ, Merrick DT, Keith RL. Tracheal dysplasia precedes bronchial dysplasia in mouse model of N-nitroso trischloroethylurea induced squamous cell lung cancer. PloS one. 2015; 10(4):e0122823.

Dwyer-Nield L, Hickey GA, Friedman M, Choo K, McArthur DG, Tennis MA, New ML, Geraci M, Keith RL. The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model. Cancer prevention research (Philadelphia, Pa.). 2017; 10(11):671-679.